Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study

Fig. 2

Two-year adverse renal and fatal outcomes among patients with chronic kidney disease with or without baseline metabolic acidosis (unadjusted analysis). The analysis included patients from the extended cohort: metabolic acidosis group, N = 17,350; normal serum bicarbonate group, N = 34,208). Abbreviation: DD40, ≥ 40 % eGFR decline, renal replacement therapy, or all-cause mortality; eGFR, estimated glomerular filtration rate. *P < 0.001: metabolic acidosis group vs. normal serum bicarbonate group

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us